24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Epitomee
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:16
Joonko founder Ilite Raz pleads guilty to a massive $27 million fraud
13:23
When product enthusiasm masquerades as market demand
09:21
The biggest blind spot in autonomous driving is the car itself
08:16
“We want to turn high performance into high reliability”: The engineer behind China’s fastest humanoid robot
More stories
Buzz
Most popular
Daily
Weekly
1
She sold her startup to Salesforce. Then she had four kids and started another one.
2
Meta loses its $1.5 billion AI recruit less than a year after hiring him
3
What made Anthropic walk away from the $6 billion Decart deal?
4
“We proved there are no sacred cows in technology”: Island founder says the company can be worth tens of billions
5
Secretive defense startup Covenant emerges from stealth with $250 million at over $1 billion valuation
More news
Epitomee
4 stories about Epitomee
Epitomee surges 200% in two days on FDA approval for weight loss pill
16.09.24
|
Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement
04.12.23
|
Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
Weight loss pill success sparks stock surge at Epitomee Medical
04.09.23
|
Adiel Eithan Mustaki
The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
Weight-Loss Pill Developer Epitomee Raises $8 Million
10.04.19
|
CTech
Epitomee develops an orally administered capsule that affects the stomach through mechanosensory stimulation, encouraging prolonged gastric emptying and giving patients the sensation of being full